Brief: Initiator Pharma Gets About SEK 12.7 Million Through Exercise Of Warrants And Directed Share Issue
Nov 6 (Reuters) - Initiator Pharma A/S INIT.TE :
* INITIATOR PHARMA IS ALLOCATED APPROXIMATELY SEK 12.7
MILLION
THROUGH EXERCISE OF WARRANTS AND DIRECTED SHARE ISSUE
Source text for Eikon: ID:nWkrLjblH
Further company coverage: INIT.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Initiator Pharma A/S
See all newsBrief: Initiator Pharma Q1 2026 Operating Loss DKK 11.4 Mln
Brief: Initiator Pharma To Fully Prioritize Pudafensine
Brief: Initiator Pharma Reports Q4 Net Revenue Of DKK 0.00
Brief: Initiator Pharma Q4 Operating Loss Widens To DKK 7 Mln
Brief: Initiator Pharma Granted European Patent For Pudafensine in FSD